Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study

You may be eligible if

• Must have been previously enrolled on TOIT protocol at St. Jude Children's Research Hospital
• Must have original bone marrow donor available and willing to participate as a donor
• Normal liver function
• Hemoglobin \>10gm/dl